MedPath

Study of Complex Intracranial Aneurysm Treatment

Not Applicable
Conditions
Intracranial Aneurysm
Interventions
Procedure: Cerebral Revascularization
Procedure: Endovascular Flow-Diversion
Registration Number
NCT03269942
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

The investigator expects that endovascular flow-diversion is superior over revascularization by postoperative modified Rankin scale (mRS) in patients with complex intracranial aneurysms.

Detailed Description

Open, prospective, controlled randomized superiority trial is conducted. The hypothesis is that endovascular flow-diversion is better than revascularization in treatment of complex intracranial aneurysms by postoperative modified Rankin Scale (mRS). Sample size was measured by Fisher exact test. Depending on a type of the procedure, the patients are divided into two groups: Endovascular Flow Diversion Procedure (include 55 patients) and Revascularization Procedure (include 55 patients). Randomization is performed by random number generation.The study was approved by Institutional Review Board

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
110
Inclusion Criteria
  • anterior circulation complex intracranial aneurysm
  • neck is more than 4 mm wide
  • dome/neck ratio of aneurysm equals or less than 2:1
  • age less than 75 years
  • ability to give informed consent (subject or legally authorized representative)
  • aneurysm is suitable for treatment to both procedures
Exclusion Criteria
  • subarachnoid hemorrhage less than 30 days ago
  • contraindications to endovascular treatment
  • atypical aneurysms (mycotic, flow-related in patients with AVM, traumatic, false)
  • informed consent refusal

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cerebral RevascularizationCerebral RevascularizationCerebral revascularization procedure with trapping of aneurysm
Endovascular Flow-DiversionEndovascular Flow-DiversionImplantation of flow-diversion device
Primary Outcome Measures
NameTimeMethod
mRS6, 12 months after procedure

Change from baseline modified Rankin Scale

Secondary Outcome Measures
NameTimeMethod
Complete aneurysm occlusion6, 12 months after procedure

Measured as: complete occlusion or residual aneurysm (included neck remnant)

Major stroke (ischemic or hemorrhagic) or neurological death related to the treatment of the target aneurysm6, 12 months after procedure

Trial Locations

Locations (1)

Novosibirsk Research Institution of Circulation Pathology

🇷🇺

Novosibirsk, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath